Transforming Real-World Insomnia Management: A Comprehensive Care Approach

Chronic insomnia is prevalent, costly, and under-treated. Despite guideline recommendations for CBT-I as a first-line treatment, most patients receive pharmacologic interventions due to systemic barriers. Nox’s integrated care model, supported by the FDA-cleared digital therapeutic Somryst and a physician-led care team, fills a significant care gap.

We’ll then learn from Frances Thorndike, PhD VP of Medical and Scientific Affairs at Nox Health.

Learning Objectives:

• Insomnia is a serious, under-recognized medical condition with broad health and economic consequences.

• CBT-I is the gold standard for treating chronic insomnia, yet access and awareness are limited.

• Nox Health offers a validated, comprehensive, and scalable care model for both short- and long-term insomnia, anchored by Somryst and human care support.

• Real-world outcomes demonstrate high engagement, long-term efficacy, and positive ROI.

• Addressing insomnia can lead to improved employee health, productivity, and healthcare savings.

Who Should Attend:

This session is ideal for HR and benefit leaders looking to improve employee wellness, reduce absenteeism, and optimize healthcare spend.

Keywords:

• Insomnia
• Cognitive Behavioral Therapy - Insomnia (CBT-I)
• Chronic condition management
• Sleep Health
• Employee Benefits